Antibiotic | P-value | |||
---|---|---|---|---|
Piperacillin/tazobactam | Resistant | 34 (94.4) | 31 (91.2) | 0.59 |
Susceptible | 2 (5.6) | 3 (8.8) | ||
Ceftazidime | Resistant | 29 (80.6) | 32 (94.1) | 0.09 |
Susceptible | 7 (19.4) | 2 (5.9) | ||
Imipenem | Resistant | 35 (97.2) | 31 (91.2) | 0.27 |
Susceptible | 1 (2.8) | 3 (8.8) | ||
Ciprofloxacin | Resistant | 30 (83.3) | 27 (79.4) | 0.67 |
Susceptible | 6 (16.7) | 7 (20.6) | ||
Gentamicin | Resistant | 35 (97.2) | 33 (97) | 0.96 |
Susceptible | 1 (2.8) | 1 (3) |
Gene type | Primer/Sequence (5′ 3′) | Product Size (bp) | References |
---|---|---|---|
F:GGTCAAGGATCTGGATTTCG | 483 | [ |
|
R:ACATGCGTGTAAATCATCGTC | |||
F:CACGGATATGCGACAAAAAGGT | 789 | [ |
|
R:GTAGCAAACGAGTGACGAAATG | |||
F:AGTGGGTGGCGAATGAGTG | 580 | [ |
|
R:TGTTCTTGTATCGGCAGGTG |
Antibiotics | P-value | |||
---|---|---|---|---|
Piperacillin/tazobactam | Resistant | 19 (90.5) | 46(93.9) | 0.61 |
Susceptible | 2 (9.5) | 3 (6.1) | ||
Ceftazidime | Resistant | 20 (95.2) | 41 (83.7) | 0.18 |
Susceptible | 1 (4.8) | 8 (16.3) | ||
Imipenem | Resistant | 19 (90.5) | 47 (95.9) | 0.36 |
Susceptible | 2 (9.5) | 2 (4.1) | ||
Ciprofloxacin | Resistant | 15 (71.4) | 42 (85.7) | 0.15 |
Susceptible | 6 (28.6) | 7 (14.3) | ||
Gentamicin | Resistant | 20 (95.2) | 47 (95.9) | 0.89 |
Susceptible | 1 (4.8) | 2 (4.1) |